Oxytocin: The Unbiased Reference Agonist in a Contested Literature

Oxytocin Research Standard

Oxytocin (CAS 50-56-6) is a cyclic, C-terminally amidated nonapeptide, supplied as a 5 mg lyophilized powder in a 3 mL vial. It shares high sequence and structural homology with arginine-vasopressin — the two differ at only positions 3 and 8 — and that near-identity across four related receptors is what makes the pair a standing test of selectivity.^[1]

Mechanism of Action & Research Context

The molecular target is the oxytocin receptor (OTR), one of four GPCRs in this family alongside the V1a, V1b and V2 vasopressin receptors.^[1]

• Oxytocin engages an unusually wide G protein range. Measured by BRET biosensor at the human OT receptor, oxytocin promotes direct engagement and activation of G_q and all the G_i/o subtypes. That breadth is the baseline against which every analogue looks biased.^[2]

• Analogues are strongly biased, and predictably so. Peptidic analogues chosen for substitutions at key structural residues all showed biased activation. No ligand except oxytocin itself activated G_oA or G_oB. With one exception, every peptide that activated G_q also activated G_i2 and G_i3 but not G_i1, G_oA or G_oB.^[2]

• Two analogues split individual G_i/o members. DNalOVT and atosiban activated only G_i1 or G_i3, failed to recruit β-arrestins, and did not induce receptor internalisation — the first clear examples of ligands differentiating individual members of the G_i/o family. Both still inhibited cell proliferation, showing a single G_i subtype-mediated pathway suffices for that response.^[2]

• The structures are now solved. Seventy years after the chemical structure of oxytocin was determined, X-ray crystallography and cryo-electron microscopy have resolved the OTR in complex with its natural agonist and with G proteins and β-arrestins — giving direct structural insight into the orthosteric pocket, the activation mechanism, and the transducer interfaces.^[1]

Research Applications

Primary fields of in vitro laboratory investigation include:

• G protein subtype engagement assays using BRET biosensors across G_q and the G_i/o family.^[2]

• Biased agonism and functional selectivity screening, with oxytocin as the unbiased reference.^[2]

• β-arrestin recruitment and receptor internalisation assays.^[2]

• Receptor selectivity panels across OTR and the V1a, V1b and V2 receptors.^[1]

• Structure-based ligand design against the solved receptor complexes.^[1]

Analytical Documentation

Purity and identity vary by manufacturing lot. Kimera Chems does not publish a single fixed purity figure for this item; refer to the batch-specific Certificate of Analysis (COA) issued for the lot received, which reflects third-party analytical testing for that lot.

References

1. Bous J, Fouillen A, Orcel H, Granier S, Bron P, Mouillac B. Structures of the arginine-vasopressin and oxytocin receptor signaling complexes. Vitam Horm. 2023;123:67–107. doi:10.1016/bs.vh.2022.12.003
2. Busnelli M, Saulière A, Manning M, Bouvier M, Galés C, Chini B. Functional selective oxytocin-derived agonists discriminate between individual G protein family subtypes. J Biol Chem. 2012;287(6):3617–3629. doi:10.1074/jbc.M111.277178

Storage & Handling

Store at controlled room temperature, sealed and protected from light.

Storage guidance is a house recommendation. Analytical documentation is per-lot release testing.

Related Research Compounds

• Fragment 176-191
• Gonadorelin
• Kisspeptin-10
• N163-166 mod6

Research Use Only Disclaimer: This product is labeled and sold "For Research Use Only - NOT FOR HUMAN CONSUMPTION." It is not a drug, dietary supplement, food, cosmetic, or medical device, and it is not approved by the FDA or any other regulator for human or veterinary use. It is supplied to approved account holders as a research chemical for laboratory use and must be handled in accordance with applicable law.